No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 23.2x · 10Y median 12.3x · 95th percentile · as of Oct 6, 2026
Annualized revenue (TTM) · by quarter, last 28
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T22:38:07.894Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T22:38:07.894Z. Latest historical point 2025-10-31.
EV/EBITDA and cash-flow multiples are withheld until their applicability to this financial-services business is verified. The lenses that apply are shown above; see also P/B and ROE.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-10-06T22:38:07.894Z. Latest historical point 2025-10-31.
EBITDA and cash-flow yields are withheld until their applicability to this financial-services business is verified. Earnings yield is shown above; see also P/B and ROE.
The latest delayed quote for OFS Credit Company, Inc. (OCCIN) stock was $24.93 as of Oct 6, 2026, 4:00 PM EDT, down 0.28% from the previous close.
Longer view (total return, dividends reinvested): past 12 months +8.5% · 3-year avg +9.9%/yr
OFS Advisor oversees the management of OFS Credit Company, Inc., which functions as a fund.
Asset Management · Chicago, IL
Next Earnings Date
Dec 9, 2026
64 days away
EPS Estimate
0.19
Revenue Est.
$8.49M
Last Quarter Results
EPS
$0.21
vs Estimate
$0.23
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1OCCIN | $683.83M | $24.93 | -0.28% | +8.54% | N/A | N/A | N/A |
| 2VINP | $686.10M | $10.75 | +0.28% | +6.70% | +2.10% | N/A | vs OCCIN |
| 3MSBI | $680.25M | $32.78 | -0.67% | +106.50% | +10.69% | +7.19% | vs OCCIN |
| 4RRBI | $677.50M | $102.89 | -0.08% | +60.41% | +16.33% | N/A | vs OCCIN |
| 5FMNB | $677.47M | $15.23 | -0.29% | +12.20% | +3.03% | +7.40% | vs OCCIN |
| 6CARE | $675.06M | $30.46 | -0.29% | +61.03% | +15.68% | +9.07% | vs OCCIN |
6.97
$8.65M
vs Estimate
$9.42M
Consensus Rating
No analyst recommendations available
Average Price Target
N/A
Low
N/A
Current
$24.93
High
N/A
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Oct 2026 | $0.19 | $0.19 | $0.19 | 1 |
| Quarter ending Jan 2027 | $0.20 | $0.20 | $0.20 | 1 |
| Quarter ending Apr 2027 | $0.21 | $0.21 | $0.21 | 1 |
| Quarter ending Jul 2027 | $0.22 | $0.22 | $0.22 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $0.92 | $0.92 | $0.92 | 1 |
| FY 2027 | $0.85 | $0.85 | $0.85 | 1 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Oct 2026 | $8.49M | $8.49M | $8.49M | 1 |
| Quarter ending Jan 2027 | $8.45M | $8.45M | $8.45M | 1 |
| Quarter ending Apr 2027 | $8.10M | $8.10M | $8.10M | 1 |
| Quarter ending Jul 2027 | $8.36M | $8.36M | $8.36M | 1 |
Annual
| Period | Low |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E uses the consensus EPS estimate for the fiscal year ending Oct 31, 2026, matching Key Metrics.
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $37.32M | $37.32M | $37.32M | 1 |
| FY 2027 | $33.11M | $33.11M | $33.11M | 1 |
